Manage episode 273108889 series 1338191
Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-191
Overview: Screening for asymptomatic conditions is an essential and important aspect of primary care. But what is the potential downstream impact to the patents and the healthcare system when low-risk individuals are screened? What are the benefits and the potential harms? Join us as we discuss a recent retrospective study on the downstream effects of low-value testing on low-risk people at their annual health exam and how this may impact your practice.
Guest: Susan Feeney, DNP, FNP-BC
Music Credit: Richard Onorato